Vitamin E supplementation in hemodialysis patients: effects on peripheral blood mononuclear cells lipid peroxidation and immune response. 1986

M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco

Lipid peroxidation and vitamin E levels in peripheral blood mononuclear cells (PBMC) were studied in 10 patients on maintenance hemodialysis. Significant increases of PBMC malonyldialdehyde (MDA) were detected, together with low vitamin E levels. After a fifteen-day-course of parenteral vitamin E supplementation, PBMC MDA reverted to normal values, while PBMC vitamin E levels remained lower than controls. In a parallel study an immunological monitoring was performed in the same patients before and after vitamin E supplementation. NK activity and PHA blastogenesis were not influenced by treatment, while a reduction of the number of OKT8+ lymphocytes were observed after vitamin E therapy. It is tempting to speculate that peroxidative damage of PBMC cell membranes in hemodialysis patients could, by impairing their functionality, influence immune responses and expression of functionally relevant membrane determinants.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins

Related Publications

M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
January 1992, Nutrition (Burbank, Los Angeles County, Calif.),
M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
November 1988, La Clinica terapeutica,
M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
September 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation,
M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
February 2001, Kidney international. Supplement,
M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
January 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
April 2008, Clinical biochemistry,
M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
January 2004, Bratislavske lekarske listy,
M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
December 2003, Clinica chimica acta; international journal of clinical chemistry,
M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
May 1995, Artificial organs,
M Taccone-Gallucci, and O Giardini, and C Ausiello, and A Piazza, and G C Spagnoli, and D Bandino, and R Lubrano, and F Taggi, and B Evangelista, and P Monaco
July 1996, Clinical chemistry,
Copied contents to your clipboard!